Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
<h4>Background</h4> Injecting-related bacterial and fungal infections are associated with significant morbidity and mortality among people who inject drugs (PWID), and they are increasing in incidence. Following hospitalization with an injecting-related infection, use of opioid agonist t...
Main Authors: | Thomas D. Brothers, Dan Lewer, Nicola Jones, Samantha Colledge-Frisby, Michael Farrell, Matthew Hickman, Duncan Webster, Andrew Hayward, Louisa Degenhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-07-01
|
Series: | PLoS Medicine |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295981/?tool=EBI |
Similar Items
-
Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.
by: Thomas D Brothers, et al.
Published: (2022-07-01) -
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
by: Nicola Jones, et al.
Published: (2022-08-01) -
The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
by: Chrianna Bharat, et al.
Published: (2022-08-01) -
Imprisonment of opioid‐dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study
by: Louisa Degenhardt, et al.
Published: (2014-04-01) -
Mitigating the risk of HIV infection with opioid substitution treatment
by: Linda R Gowing, et al.
Published: (2013-02-01)